Department of Biotechnology, Pondicherry University, Kalapet, Puducherry, India.
Centre for Excellence in Nanobio Translational Research, Department of Pharmaceutical Technology, Anna University, BIT Campus, Tamil Nadu, Tiruchirappalli, India.
Environ Sci Pollut Res Int. 2024 Jul;31(34):46558-46574. doi: 10.1007/s11356-023-27524-x. Epub 2023 May 18.
Nisin, a thermostable, approved food preservative, has limited therapeutic applications because of its high pH and proteolytic enzyme instability. The unavailability of a rapid, simple method of detection also restricts the research of nisin. The objective of this study was to adapt the simple, rapid protein estimation method of detection for nisin formulation and to formulate and evaluate site-specific nanoformulation for therapeutic applications, viz. colon cancer, and anti-bacterial action. Three nanoformulations of nisin with chitosan, gellan gum, and dextran (ECN, EGN, and EDN) were prepared and characterized in vitro. Among three, EGN was selected as a good formulation based on its size surface charge, morphology, drug loading, and release characteristics. FT-IR and DSC revealed the interaction pattern and stability nature. The stability of nisin in an alkaline environment was confirmed by CD. Its therapeutic applications were proved by efficiency against colon cancer cells evaluated by MTT assay and AO/EB staining using Caco-2 cell lines. The in situ sol-gel mechanism imparted by gellan gum was proved the sole reason for the stability and activity of nisin in EGN at lower GIT. This was confirmed (using rheometer) by shear-thickening characteristics of formulation EGN in simulated colon fluid. The antibacterial activity against Staphylococcus aureus by disk diffusion method was also performed to confirm the retention of antimicrobial activity of nisin in EGN. Hence, gellan gum-nisin colloidal nanoparticles are found good candidates for drug delivery at lower GIT and stabilizing alkaline food materials.
乳链菌肽是一种热稳定的批准使用的食品防腐剂,由于其较高的 pH 值和蛋白水解酶不稳定性,其治疗应用有限。由于缺乏快速、简单的检测方法,也限制了乳链菌肽的研究。本研究的目的是适应乳链菌肽配方的简单、快速的蛋白质检测方法,并对用于治疗应用(即结肠癌和抗菌作用)的特定部位纳米制剂进行配方和评估。用壳聚糖、结冷胶和葡聚糖(ECN、EGN 和 EDN)制备了三种乳链菌肽纳米制剂,并进行了体外表征。在这三种制剂中,EGN 因其粒径、表面电荷、形态、药物负载和释放特性而被选为良好的制剂。傅里叶变换红外光谱和差示扫描量热法揭示了相互作用模式和稳定性。通过圆二色谱法证实了乳链菌肽在碱性环境中的稳定性。通过 MTT 测定法评估对结肠癌细胞的疗效和使用 Caco-2 细胞系的 AO/EB 染色来证明其在结肠癌治疗中的应用。通过凝胶渗透色谱法证实结冷胶赋予的原位溶胶-凝胶机制是 EGN 在较低的胃肠道中稳定和保持乳链菌肽活性的唯一原因。这通过流变仪证实了制剂 EGN 在模拟结肠液中的剪切变稠特性。还通过圆盘扩散法对抗金黄色葡萄球菌的抗菌活性进行了测试,以确认乳链菌肽在 EGN 中的抗菌活性得以保留。因此,结冷胶-乳链菌肽胶体纳米颗粒被认为是在较低的胃肠道中进行药物输送和稳定碱性食品材料的良好候选物。